Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 24.80
-0.20 (-0.80%)
Nov 13, 2026, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.74 billion as of November 13, 2026. It is the 26,288th most valuable company in the world and the 1,434th biggest in Taiwan. Its market cap has increased by 6.29% in one year.
Market Cap
2.74B
Enterprise Value
4.02B
Revenue
54.34M
Global Rank
Country Rank
#1,434 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.74B, a decrease of -31.68%. That is a compound annual growth rate of -3.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.74B | -5.65% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.33B |
| Pharmosa Biopharm | 3.19B |
| Formosa Pharmaceuticals | 3.03B |
| Sagittarius Life Science | 3.03B |
| Shine-On BioMedical | 2.90B |
| BioGend Therapeutics | 2.76B |
| Senhwa Biosciences | 2.67B |
| Energenesis Biomedical CO.,LTD. | 2.62B |